Guerenne, L., Beurlet, S., Said, M., Gorombei, P., Le Pogam, C., Guidez, F., . . . Krief, P. (2016). GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways. J Hematol Oncol.
Chicago-tyylinen lähdeviittausGuerenne, Laura, et al. "GEP Analysis Validates High Risk MDS and Acute Myeloid Leukemia Post MDS Mice Models and Highlights Novel Dysregulated Pathways." J Hematol Oncol 2016.
MLA-viiteGuerenne, Laura, et al. "GEP Analysis Validates High Risk MDS and Acute Myeloid Leukemia Post MDS Mice Models and Highlights Novel Dysregulated Pathways." J Hematol Oncol 2016.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.